ZSZhiqiang Song

Zhiqiang Song

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhiqiang Song has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Lan Ge

    Department of Dermatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China

    1 shared publication
  • Lan Ge

    Department of Dermatology, The First Affiliated Hospital of Army Medical University, Chongqing, People’s Republic of China

    1 shared publication
  • Ming Wan

    Shumei Cosmetic Clinic in Lianhu District, Xi’an 710075, China

    1 shared publication
  • Yaguang Wu

    Department of Dermatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China

    1 shared publication
  • Yaguang Wu

    Department of Dermatology, Southwest Hospital of Third Military Medical University, Chongqing, People’s Republic of China

    1 shared publication
  • Yaoying Li

    Department of Dermatology, The First Affiliated Hospital of Army Medical University, Chongqing, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Differential Diagnosis of Rosacea Using Machine Learning and Dermoscopy

    by Lan Ge, Yaoying Li, Yaguang Wu, Ziwei Fan, Zhiqiang Song

    Introduction: Rosacea is a common chronic inflammatory disease occurring on the face, whose diagnosis is mainly based on symptoms and physical signs. Due to some overlap in symptoms and signs with other inflammatory skin diseases, young and inexperienced doctors often make misdiagnoses and missed diagnoses in clinical practices. We analyze the results of skin physiology and dermatoscopy using machine learning method and identify the characteristics of acne rosacea, which differentiate it from other common facial inflammatory skin diseases so as to improve the accuracy of clinical and differential diagnosis of rosacea. Methods: A total of 495 patients who were jointly diagnosed by two experienced doctors were included. Basic data, clinical symptoms, physiological skin detection, and dermatoscopy results were collected, and the clinical characteristics of rosacea and other common facial inflammatory diseases were summarized according to the descriptive analysis results. The model was established using a machine learning method and compared with the judgment results of young and inexperienced doctors to verify whether the model can improve the accuracy of clinical diagnosis and differential diagnosis of rosacea. Results: The proportion of yellow and red halos, vascular polygons, as well as follicular pustules, showed by dermatoscopy, and the melanin index in physiological skin detection revealed statistical significance in differentiating rosacea and other common facial inflammatory diseases (all P < 0.01). After adopting the machine learning, we found that GBM (Gradient Boosting Machine) algorithm was the best, and the error rate of this model in the validation set was 5.48%. In the final man-machine comparison, the accuracy of the GBM algorithm model for the classification of skin disease was significantly higher than that of young and inexperienced doctors. Conclusion: Dermatoscopy combined with machine learning can effectively improve the diagnosis and differential diagnosis accuracy of rosacea and other facial inflammatory skin diseases.


  • Open Access

    Metformin Increases Sensitivity of Melanoma Cells to Cisplatin by Blocking Exosomal-Mediated miR-34a Secretion

    by Lan Ge, Yaguang Wu, Ming Wan, Yi You, Zhifang Zhai, Zhiqiang Song

    Melanoma, also known as malignant melanoma, is a type of cancer derived from the pigment-containing cells known as melanocytes. Cisplatin (CDDP) is widely used in the treatment of different types of tumors with high response rates, but it generally has low efficiency in melanoma. This study aimed to investigate whether metformin could sensitize the melanoma cell line A375 to cisplatin. Our results for the first time indicated that CDDP increased the miR-34a secretion by exosomes in melanoma A375 cells, which was, at least partially, related to the cisplatin resistance of melanoma cells. Moreover, metformin significantly sensitized A375 cells to cisplatin. Mechanistically, metformin significantly blocked the exosome-mediated miR-34a secretion induced by cisplatin. Our study not only reveals a novel mechanism that exosomal secretion of miR-34a is involved in the cisplatin resistance of melanoma cells but also provides a promising therapeutic strategy by synergistic addition of metformin.